journal article·2018-03-12

Incorporation of Calcium Sulfate Dihydrate into Hydroxyapatite Microspheres To Improve the Release of Bone Morphogenetic Protein-2 and Accelerate Bone Regeneration

Jaeuk Baek, Hyun Lee, Tae-Sik Jang, Juha Song, Hyoun-Ee Kim, Hyun-Do Jung

Publisher page

Abstract

In this study, hydroxyapatite (HA)-based microspheres with the ability to deliver bone morphogenetic protein-2 (BMP-2) were developed for accelerating bone regeneration. The incorporation of calcium sulfate dihydrate (CSD) in the HA matrix improved the rate of BMP-2 release from the microspheres. Under physiological conditions, the CSD fully degraded within 7 days and generated pore channels in the microspheres. The porosity and pore size of the HA-CSD microspheres after CSD degradation were 34.3% ± 4.2% and 11.5 ± 2.4 μm, respectively, significantly larger than those of the HA microspheres (23.9% ± 3.1% and 8.7 ± 0.9 μm, respectively). The increased porosity directly affected the rate of BMP-2 release from the microspheres. An in vitro experiment showed that both the BMP-2 release rate and the total amount of BMP-2 released increased considerably when incorporating the HA microspheres with CSD. BMP-2 was released slowly from the HA microspheres for up to 6 weeks. BMP-2 release was notably improved in the HA-CSD biphasic microspheres compared to the microspheres without CSD; the rate of release was 2.4-times faster due to the pores created by CSD dissolution after 7 days. Prior to animal testing, in vitro cell tests were performed to evaluate the biocompatibility of the HA-CSD microspheres. During CSD dissolution, biocompatible bone-like apatite precipitated on the cell surfaces, and preosteoblasts grew on the microspheres. In vivo experiments using a rabbit lateral femoral condyle defect model demonstrated that the level of bone regeneration was significantly enhanced by mineralization on the surface, generated additional pores as well as improved BMP-2 release behavior. The HA-CSD microspheres accelerated new bone growth to fill the entire defect in 6 weeks, corresponding to a 170% improvement in performance compared to the HA microspheres.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty · Periodontal Regeneration and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Materials Science and Engineering, Seoul National University, Seoul 151-742, South Korea

Chemical and Biomedical Engineering, Nanyang Technological University, 70 Nanyang Drive, Singapore 637457, Singapore

Biomedical Implant Convergence Research Center, Advanced Institutes of Convergence Technology, Suwon 443-270, South Korea

Liquid Processing & Casting Technology R&D Group, Korea Institute of Industrial Technology, Incheon 21999, Korea

Funding

National Research Foundation of Korea · Ministry of Trade, Industry and Energy

References (40)

Show source-provided references
1. 10.1007/s00223-016-0140-810.1007/s00223-016-0140-8 ↗
2. 10.1177/088532821349179010.1177/0885328213491790 ↗
3. 10.1002/jbm.a.3204910.1002/jbm.a.32049 ↗
4. 10.3390/ma1004036710.3390/ma10040367 ↗
5. 10.1016/j.jiec.2011.11.00110.1016/j.jiec.2011.11.001 ↗
6. 10.1007/BF0012038610.1007/BF00120386 ↗
7. 10.1089/ten.teb.2013.022110.1089/ten.teb.2013.0221 ↗
8. 10.1021/cr800442210.1021/cr8004422 ↗
9. 10.1563/0-742.110.1563/0-742.1 ↗
10. 10.1016/j.biomaterials.2005.01.00610.1016/j.biomaterials.2005.01.006 ↗
11. 10.1002/jbm.b.3289510.1002/jbm.b.32895 ↗
12. 10.1007/s10856-008-3435-010.1007/s10856-008-3435-0 ↗
13. 10.1016/j.actbio.2010.01.03610.1016/j.actbio.2010.01.036 ↗
14. 10.1002/jbm.b.3179810.1002/jbm.b.31798 ↗
15. 10.1016/j.matlet.2012.02.11410.1016/j.matlet.2012.02.114 ↗
16. 10.1111/j.1551-2916.2010.04314.x10.1111/j.1551-2916.2010.04314.x ↗
17. 10.1016/j.addr.2012.01.00810.1016/j.addr.2012.01.008 ↗
18. 10.1007/s11999-013-3261-710.1007/s11999-013-3261-7 ↗
19. 10.7326/0003-4819-158-12-201306180-0000610.7326/0003-4819-158-12-201306180-00006 ↗
20. 10.1016/j.actbio.2013.05.02910.1016/j.actbio.2013.05.029 ↗
21. 10.1016/j.ceramint.2016.01.18910.1016/j.ceramint.2016.01.189 ↗
22. 10.1016/j.actbio.2012.11.01710.1016/j.actbio.2012.11.017 ↗
23. 10.1163/15685620677836600410.1163/156856206778366004 ↗
24. 10.1016/j.biomaterials.2006.09.00210.1016/j.biomaterials.2006.09.002 ↗
25. 10.1097/00003086-200202000-0000610.1097/00003086-200202000-00006 ↗
26. 10.1002/jbm.b.3039810.1002/jbm.b.30398 ↗
27. 10.1016/j.msec.2013.12.03410.1016/j.msec.2013.12.034 ↗
28. 10.1088/1748-6041/1/4/00310.1088/1748-6041/1/4/003 ↗
29. 10.1002/jbm.b.3126910.1002/jbm.b.31269 ↗
30. 10.1002/jor.2004910.1002/jor.20049 ↗
31. 10.1016/j.biomaterials.2014.10.02710.1016/j.biomaterials.2014.10.027 ↗
32. 10.4015/S101623721550028310.4015/S1016237215500283 ↗
33. 10.1177/088532821663797810.1177/0885328216637978 ↗
34. 10.1016/j.archoralbio.2016.10.00610.1016/j.archoralbio.2016.10.006 ↗
35. 10.4103/1735-3327.9295910.4103/1735-3327.92959 ↗
36. 10.1557/JMR.2004.034910.1557/JMR.2004.0349 ↗
37. 10.1016/j.partic.2013.10.00210.1016/j.partic.2013.10.002 ↗
38. 10.1016/j.biomaterials.2003.09.00710.1016/j.biomaterials.2003.09.007 ↗
39. 10.1007/s11999-010-1321-910.1007/s11999-010-1321-9 ↗
40. 10.1002/jps.260052121010.1002/jps.2600521210 ↗